A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
Christopher TwelevesMichael SabelDaniel CheckettsSharon MillerBola TayoMaria JoveLucy BrazilSusan C Shortnull nullPublished in: British journal of cancer (2021)
ClinicalTrials.gov: Part 1- NCT01812603; Part 2- NCT01812616.